Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins.
about
Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationHigh expression and frequently humoral immune response of melanoma-associated antigen D4 in gliomaIndustrial production of recombinant therapeutics in Escherichia coli and its recent advancements.Affinity labeling of hepatitis C virus replicase with a nucleotide analogue: identification of binding site.Introduction of plasmid encoding for rare tRNAs reduces amplification bias in phage display biopanningOver-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.Fusion to the Lysosome Targeting Signal of the Invariant Chain Alters the Processing and Enhances the Immunogenicity of HIV-1 Reverse TranscriptaseIdentification and evaluation of anti hepatitis C virus phytochemicals from Eclipta albaHepatitis C virus NS5A protein modulates template selection by the RNA polymerase in in vitro system.Fusion to Flaviviral Leader Peptide Targets HIV-1 Reverse Transcriptase for Secretion and Reduces Its Enzymatic Activity and Ability to Induce Oxidative Stress but Has No Major Effects on Its Immunogenic Performance in DNA-Immunized Mice.Anti-HCV Activity from Semi-purified Methanolic Root Extracts of Valeriana wallichii.The Interaction between the RNA-Dependent RNA-Polymerase of the Hepatitis Virus and RNA MatricesFed-batch cultivation of Escherichia coli expressed designer hepatitis C virus diagnostic intermediate and its evaluation.Expression of a recombinant extracellular fragment of human vascular endothelial growth factor receptor VEGFR1 in E. coli.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.
P2860
Q28830384-FE12B859-F231-44A6-9777-75AADFF12D27Q33802891-13BBBE43-0D4C-49DB-AB65-9487751B620BQ34247760-4A61AADB-CA83-4931-B2D5-5982D57D1F8FQ34523107-E6469A66-DAA0-4994-9D87-D898F253CD83Q35555227-FEED1B15-75B0-41A6-A926-465E59F8F4CDQ37348347-56363A73-0054-4C1B-B210-145C10324990Q37722979-402F99C6-C4C9-450D-A671-84C6D74DD694Q39268320-A507F74C-6B23-4B48-B57E-765F25F98416Q39906570-1296A805-3CEF-4497-8517-F9DD87E506E9Q40119086-50407A61-E2F5-4C6D-B9E3-4A28B7006203Q40375330-EEA9A5B9-9F92-4090-ADEB-6A2CA133A59FQ41894340-B171B0BB-456C-4678-938E-0C57BCAEBD86Q42991194-9E789708-5098-4EFE-AEA5-24D22B3E0F4FQ54520997-2D3E16C2-DBD4-44FB-AF51-E3AE304B1858Q55154648-ADAE2D7F-BC7E-44F3-B027-BBF590E57F01
P2860
Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@en
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@nl
type
label
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@en
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@nl
prefLabel
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@en
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@nl
P2093
P1476
Development of the system ensu ...... ctural NS5B and NS5A proteins.
@en
P2093
Anna N Korovina
Dmitry A Kostyuk
Marina K Kukhanova
Sergey N Kochetkov
Vera L Tunitskaya
Vladimir O Rechinsky
P356
10.1016/J.PEP.2006.02.011
P577
2006-03-10T00:00:00Z